Straight to the heart: Protecting the patient's heart during chemotherapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39642857.
- Also identified by DOI 10.1016/j.stem.2024.10.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
How do we protect the heart during chemotherapy with the anthracycline drug class? Tackling this question, Liu et al. combined pluripotent stem cell models, CRISPR genetic screens, and molecular modeling to identify indisulam as a potential cardioprotective drug in this issue of Cell Stem Cell.
Medical subject headings
- Antineoplastic Agents